V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009950 | 190002912 | 1.63 | 43 | Palliative (P) | 2019-08-25 | 2019-08-25 | Cisplatin + Radiotherapy | 02 | N | EURAMOS TRIAL | 100607227 |
| 190009952 | 190002913 | null | null | null | null | 2016-09-23 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | null | null | DOXORUBICIN + METHOTREXATE | 100639670 |
| 190009956 | 190002914 | 1.76 | 65.2 | Curative (C) | 2020-03-14 | 2020-03-14 | Cisplatin + Doxorubicin | 01 | null | CISPLATIN + DOXORUBICIN | 101290496 |
| 190009958 | 190002915 | 1.53 | null | Palliative (P) | 2017-02-14 | 2017-02-16 | Cisplatin + Doxorubicin | 01 | N | CISPLATIN + DOXORUBICIN | 100130592 |
| 190009961 | 190002916 | null | null | null | null | 2017-03-07 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100674363 |
| 190009966 | 190002917 | null | null | null | null | 2016-05-08 | Dox + HD Mtx (post PAM) | null | null | DOXORUBICIN + METHOTREXATE | 101738104 |
| 190009967 | 190002918 | null | null | null | null | 2018-05-09 | EW EuroEwing 2012 Arm B VDC | null | null | OST AI | 101253879 |
| 190009970 | 190002919 | null | null | null | null | 2016-09-10 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 100435325 |
| 190009977 | 190002920 | null | null | null | null | 2019-11-03 | EW EuroEwing 2012 Arm A VIDE | null | null | EURAMOS TRIAL | 101725784 |
| 190009978 | 190002921 | 1.79 | 61.8 | Palliative (P) | 2021-09-22 | 2021-10-07 | EW EuroEwing 2012 Arm B VDC | 02 | N | EW EUROEWING 2012 ARM B VDC | 100339864 |
| 190009987 | 190002922 | null | null | null | null | 2016-05-16 | OCTREOTIDE | null | null | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 100962902 |
| 190009989 | 190002923 | null | null | null | null | 2021-07-16 | Oxaliplatin + Modified de Gramont | null | null | PAZOPANIB | 101009189 |
| 190009993 | 190002924 | 1.75 | 32.2 | Curative (C) | 2018-03-02 | 2018-03-04 | Carboplatin AUC 6 - 10 | 02 | N | MAP | 101404318 |
| 190009994 | 190002925 | null | null | null | null | 2016-10-20 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 101632471 |
| 190009996 | 190002926 | 1.1 | 50.6 | Palliative (P) | 2021-04-05 | 2021-04-05 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 101230444 |
| 190009998 | 190002927 | 1.5 | 74 | Curative (C) | 2017-08-18 | 2017-08-21 | EW EuroEwing 2012 Arm A VIDE | 02 | Y | DOXORUBICIN + HD MTX | 100939454 |
| 190009999 | 190002928 | null | null | null | null | 2021-05-10 | Carboplatin+Fluorouracil 4 or 5 day | null | null | EURAMOS TRIAL | 101464017 |
| 190010003 | 190002930 | 1.58 | 102.6 | Palliative (P) | 2017-09-12 | 2017-09-16 | EW EuroEwing 2012 Arm B VDC | N | N | EW EUROEWING 2012 ARM B VDC | 101650109 |
| 190010004 | 190002931 | null | null | null | null | 2015-03-03 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 100734524 |
| 190010007 | 190002933 | null | null | null | null | 2016-06-13 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | null | null | DOXORUBICIN | 100741640 |
| 190010011 | 190002934 | 1.64 | 72.4 | Curative (C) | 2019-11-19 | 2019-12-25 | OST Euramos 1 Closed Trial - AP | 02 | Y | OST AP | 100983073 |
| 190010012 | 190002935 | null | null | null | null | 2019-12-26 | BEP 3 day | null | null | EURO-EWING | 101156255 |
| 190010014 | 190002936 | 1.78 | 46 | Palliative (P) | 2018-04-10 | 2018-04-11 | Gemcitabine weekly | 01 | N | EURO-EWING | 101366220 |
| 190010015 | 190002937 | null | null | null | null | 2019-09-15 | EW EuroEwing 2012 Arm A VIDE | null | null | DOXORUBICIN + METHOTREXATE | 101839599 |
| 190010020 | 190002939 | null | 72 | Curative (C) | 2018-02-15 | 2018-02-22 | OST Euramos 1 Closed Trial - AP | N | N | GC INT GUIDE EXCRANIAL GERMCELL JEB | 100707734 |
| 190010034 | 190002943 | 0 | 51 | Curative (C) | 2016-10-27 | 2016-10-27 | OST Euramos 1 Closed Trial - AP | 02 | N | OST AP | 101580038 |
| 190010035 | 190002944 | null | null | null | null | 2018-01-21 | CISPLATIN + ETOPOSIDE | null | null | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 101667228 |
| 190010037 | 190002945 | 1.72 | 82.7 | Curative (C) | 2019-06-15 | 2019-06-16 | ECarboX | 02 | N | CAV | 101543191 |
| 190010041 | 190002946 | null | null | null | null | 2018-12-09 | Capecitabine + Oxaliplatin 21day | null | null | CETUXIMAB + RT | 101313349 |
| 190010044 | 190002947 | null | 106.7 | null | 2019-05-15 | 2019-05-15 | MAP | 01 | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101484428 |
| 190010045 | 190002948 | 1.65 | 131 | Palliative (P) | 2019-11-24 | 2019-11-24 | EW EuroEwing 2012 Arm B VDC | 01 | N | EW EUROEWING 2012 ARM B VDC | 100182411 |
| 190010047 | 190002949 | 1.67 | 50 | Curative (C) | 2018-03-27 | 2018-03-29 | MAP | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100937280 |
| 190010048 | 190002950 | 1.81 | 70 | Palliative (P) | 2019-08-25 | 2019-08-28 | CAPECITABINE + OXALIPLATIN | 02 | N | DOXORUBICIN + METHOTREXATE | 100546573 |
| 190010050 | 190002951 | null | null | null | null | 2019-12-18 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100348450 |
| 190010052 | 190002952 | 1.66 | 109 | 03 | 2018-04-19 | 2018-04-22 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 101557901 |
| 190010065 | 190002956 | 0 | 8.4 | Curative (C) | 2017-11-24 | 2017-11-28 | PAM | 2 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101243287 |
| 190010073 | 190002959 | null | null | null | null | 2019-06-01 | Carboplatin + Vinorelbine Oral | null | null | DOXORUBICIN + HD MTX | 100031238 |
| 190010076 | 190002960 | null | null | null | null | 2017-03-13 | EW EuroEwing 2012 Arm B VDC | null | null | OST AI | 100360558 |
| 190010079 | 190002961 | null | null | null | null | 2019-01-15 | EURO-EWING | null | null | DOXORUBICIN + METHOTREXATE | 100830105 |
| 190010084 | 190002963 | null | null | null | 2019-06-13 | 2019-06-13 | DOCETAXEL + GEMCITABINE | 02 | null | DOXORUBICIN + METHOTREXATE | 100996778 |
| 190010085 | 190002964 | null | null | null | null | 2016-09-17 | VIDE | null | null | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 100022744 |
| 190010087 | 190002966 | null | null | null | null | 2017-02-19 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101303054 |
| 190010088 | 190002967 | null | null | null | null | 2019-05-28 | OST Euramos 1 Closed Trial - Ai | null | null | DOXORUBICIN + METHOTREXATE | 100675486 |
| 190010089 | 190002968 | 1.67 | 69.4 | null | 2017-08-22 | 2017-08-28 | Carboplatin AUC 2 - 5 | 02 | null | LANREOTIDE | 100313206 |
| 190010096 | 190002971 | null | null | null | null | 2018-08-05 | Trial Unspecified | null | null | DOXORUBICIN + IFOSFAMIDE | 100180143 |
| 190010099 | 190002973 | null | null | null | null | 2016-07-30 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101049103 |
| 190010105 | 190002975 | 1.63 | 83 | Palliative (P) | 2018-06-05 | 2018-06-20 | Epirubicin | 02 | Y | CARBOPLATIN + ETOPOSIDE | 101131327 |
| 190010106 | 190002976 | null | 74.4 | null | 2017-10-27 | 2017-10-29 | EW EuroEwing 2012 Arm A VIDE | 02 | null | MAP | 100209485 |
| 190010108 | 190002977 | null | null | null | null | 2016-03-13 | FEC | null | null | EW EUROEWING 2012 ARM A VAI | 100931773 |
| 190010109 | 190002978 | null | null | null | null | 2017-10-29 | LANREOTIDE | null | null | MIFAMURTIDE | 100844569 |